$\require{mediawiki-texvc}$
  • 검색어에 아래의 연산자를 사용하시면 더 정확한 검색결과를 얻을 수 있습니다.
  • 검색연산자
검색도움말
검색연산자 기능 검색시 예
() 우선순위가 가장 높은 연산자 예1) (나노 (기계 | machine))
공백 두 개의 검색어(식)을 모두 포함하고 있는 문서 검색 예1) (나노 기계)
예2) 나노 장영실
| 두 개의 검색어(식) 중 하나 이상 포함하고 있는 문서 검색 예1) (줄기세포 | 면역)
예2) 줄기세포 | 장영실
! NOT 이후에 있는 검색어가 포함된 문서는 제외 예1) (황금 !백금)
예2) !image
* 검색어의 *란에 0개 이상의 임의의 문자가 포함된 문서 검색 예) semi*
"" 따옴표 내의 구문과 완전히 일치하는 문서만 검색 예) "Transform and Quantization"

통합검색

도움말도움말
상세검색 다국어 입력

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

특허 상세정보

MyON담기
내보내기 페이스북 공유 카카오톡 공유

Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols

특허상세정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판) A01N-061/00    A61K-031/00   
미국특허분류(USC) 514/784 ; 514/947 ; 514/772 ; 514/785
출원번호 US-0218702 (1988-07-13)
발명자 / 주소
출원인 / 주소
인용정보 피인용 횟수 : 165  인용 특허 : 9
초록
▼

Penetration-enhancing pharmaceutical compositions for topical transepidermal and percutaneous application are disclosed which are non-irritating to the skin. These compositions are made up of a safe and effective amount of an active pharmaceutical permeant, including hydrophilic salt forms, contained in a novel penetration-enhancing vehicle comprising, (i) 1-95% w. of a cell-envelope disordering compound selected from the group consisting of oleic acid, oleyl alcohol, glycerol monoleate, glycerol dioleate, glycerol trioleate and mixtures thereof, (ii) 5-...

대표
청구항
▼

A pharmaceutical composition for topical application having penetration-enhancing properties consisting essentially of: (a) a safe and effective amount of an active pharmaceutical agent contained in, (b) a penetration-enhancing vehicle exclusive of diols and N-cyclic solvents consisting essentially of: (i) 1-95% by weight of one or more cell-envelope disordering compounds selected from the group consisting of oleic acid, oleyl alcohol, glycerol esters of oleic acid and mixtures thereof; (ii) 5-75% by weight of a lower alkanol selected from the group cons...

이 특허에 인용된 특허 (9)

  1. Sato Susumu (Ibaraki JPX) Takakura Umiko (Ibaraki JPX) Tamada Mitsuru (Ibaraki JPX). Base composition for external preparations, pharmaceutical composition for external use and method of promoting percutan. USP1986064593048.
  2. Campbell, Patricia S.; Chandrasekaran, Santosh K.. Dosage for coadministering drug and percutaneous absorption enhancer. USP1983044379454.
  3. Cooper, Eugene R.. Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one. USP1985124557934.
  4. Cooper, Eugene R.. Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone. USP1985084537776.
  5. Cooper, Eugene R.; Loomans, Maurice E.; Fawzi, Mahdi B.. Penetrating topical pharmaceutical compositions containing corticosteroids. USP1985114552872.
  6. Campbell Patricia S. (Palo Alto CA) Chandrasekaran Santosh K. (Palo Alto CA). Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer. USP1984074460372.
  7. Sloan, Kenneth B.. Soft tertiary amine esters of bio-affecting carboxylic acids. USP1983044381307.
  8. Gale Robert M. (Los Altos CA) Goetz Victor (Palo Alto CA) Lee Eun S. (Redwood City CA) Taskovich Lina T. (Palo Alto CA) Yum Su I. (Los Altos CA). Transdermal administration of fentanyl and device therefor. USP1986054588580.
  9. Sanders Harold F. (San Jose CA) Cheng Yu-Ling (Cupertino CA) Enscore David J. (Sunnyvale CA) Libicki Shari B. (Palo Alto CA). Transdermal drug delivery device with dual permeation enhancers. USP1988084764379.

이 특허를 인용한 특허 피인용횟수: 165

  1. Singh, Parminder; Cleary, Gary W.; Kulichikhin, Valery G.; Antonov, Sergey. Adhesive composition. USP2016019242021.
  2. Tokumoto, Seiji; Machida, Kazuya; Kurokawa, Nao; Namiki, Rie. Adjuvant composition, adjuvant preparation containing same, and kit. USP2018069993549.
  3. Arnold, John Jefferson; Huang, Chun Ming; Meezan, Elias; Pillion, Dennis J.; Tang, De Chu C.. Alkyl-glycoside enhanced vaccination. USP2009047524510.
  4. Harry A. Dugger, III. Antihistamine sprays and ointments for relief of delayed contact dermatitis. USP2002056391282.
  5. Barman,Shikha P.; Schramm,Helice A.; Warner,Nicholas F.. Biocompatible chemically crosslinked hydrogels for glucose sensing. USP2008107432069.
  6. Dugger, III, Harry A.; Abd El-Shafy, Mohammed. Buccal, polar and non-polar spray containing ondansetron. USP2015079078816.
  7. Dugger, III, Harry A.; Abd El Shafy, Mohammed. Buccal, polar and non-polar spray containing zolpidem. USP2009127632517.
  8. Dugger, III, Harry A.; Abd El-Shafy, Mohammed. Buccal, polar and non-polar spray containing zolpidem. USP2012088236285.
  9. Johnson Mark E. ; Mitragotri Samir S. ; Blankschtein Daniel ; Langer Robert S. ; Pishko Michael ; Kost Joseph,ILX. Chemical and physical enhancers and ultrasound for transdermal drug delivery. USP1999095947921.
  10. Kohane, Daniel S.; Sagie, Itay; Simons, Emmanuel J.. Chemical permeation enhancers enhance nerve blockade by toxins. USP2014028658699.
  11. Li Chensheng. Composition and methods for transdermal delivery of acid labile drugs. USP2000026024974.
  12. Carrara Dario,ARX. Composition for controlled and sustained transdermal administration. USP2001056231885.
  13. Carrara,Dario; Porto,Gabriel; Rodriguez,Jorge. Composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels. USP2008077404965.
  14. Carrano Richard A. ; Wang Bin,CNX ; Weiner David B.. Compositions and methods for delivery of genetic material. USP2001036197755.
  15. Carrano Richard A. ; Wang Bin,CNX ; Weiner David B.. Compositions and methods for delivery of genetic material. USP1999105962428.
  16. Carrano Richard A. ; Wang Bin,CNX ; Weiner David B.. Compositions and methods for delivery of genetic material. USP1998045739118.
  17. Gonzalez-Zugasti, Javier; Boccuti, A. David; Chickering, III, Donald E.; Michelman, Mark; Haghgooie, Ramin; Davis, Shawn; James, Scott; Dadgar, Maisam; Fisher, Greg; Miller, Richard L.; Morse, Christopher J.. Delivering and/or receiving fluids. USP2014098827971.
  18. Gonzalez-Zugasti, Javier; Boccuti, A. David; Chickering, III, Donald E.; Michelman, Mark; Haghgooie, Ramin; Davis, Shawn; James, Scott; Dadgar, Maisam; Fisher, Greg; Miller, Richard L.; Morse, Christopher J.; Bernstein, Howard; Levinson, Douglas A.. Delivering and/or receiving fluids. USP2017089730624.
  19. Gonzalez-Zugasti, Javier; Boccuti, A. David; Chickering, III, Donald E.; Michelman, Mark; Haghgooie, Ramin; Davis, Shawn; James, Scott; Dadgar, Maisam; Fisher, Greg; Miller, Richard L.; Morse, Christopher J.; Bernstein, Howard; Levinson, Douglas A.. Delivering and/or receiving fluids. USP2014098821412.
  20. Lundy, Charles E.; Cleary, Gary Wynn; Faasse, Adrian Louis; Marcoux, Michael George; Mudumba, Sreenivasu. Dermal, transdermal, mucosal or transmucosal ingredient delivery devices. USP2011077976867.
  21. Breitenbach, Armin. Device for the transdermal administration of a rotigotine base. USP2013108545872.
  22. Zahradka, Peter. Devices and compounds for treating arterial restenosis. USP2003046544541.
  23. Bernstein, Howard; Chickering, III, Donald E.; Levinson, Douglas A.; Walt, David R.; Davis, Shawn; Haghgooie, Ramin. Devices and techniques associated with diagnostics, therapies, and other applications, including skin-associated applications. USP2015089113836.
  24. Bernstein, Howard; Chickering, III, Donald E.; Levinson, Douglas A.; Walt, David R.; Davis, Shawn; Haghgooie, Ramin; Langer, Robert S.; Blicharz, Timothy M.. Devices and techniques associated with diagnostics, therapies, and other applications, including skin-associated applications. USP2017109775551.
  25. Enscore David J. ; Campbell Patricia S. ; Nedberge Diane ; Frame Richard D.. Drug delivery devices and process of manufacture. USP2001016174545.
  26. Enscore David J. ; Campbell Patricia S. ; Nedberge Diane ; Frame Richard D.. Drug delivery devices and process of manufacture. USP1999126007837.
  27. Kost Joseph,ILX ; Pliquett Uwe,DEX ; Mitragotri Samir S. ; Langer Robert S. ; Weaver James C.. Effect of electric field and ultrasound for transdermal drug delivery. USP2000036041253.
  28. Yanagida Takeshi,JPX ; Sakamoto Okihiko,JPX. External skin treatment composition. USP2000026024941.
  29. Venkateshwaran Srinivasan ; Fikstad David ; Patel Sonal R.. Fatty acid esters of glycolic acid and its salts. USP1999065912009.
  30. Venkateshwaran Srinivasan ; Fikstad David ; Patel Sonal R.. Fatty acid esters of lactic acid salts as permeation enhancers. USP1999095952000.
  31. Carrara,Dario Norberto R.; Grenier,Arnaud; Besse,Celine; Simes,Stephen M.; Lehman,Leah M.. Formulations for transdermal or transmucosal application. USP2008127470433.
  32. Carrara,Dario Norberto R.; Grenier,Arnaud; Besse,Celine; Simes,Stephen M.; Lehman,Leah M.. Formulations for transdermal or transmucosal application. USP2007047198801.
  33. Charles, Matthew. Formulations of human tissue kallikrein-1 for parenteral delivery and related methods. USP2017049616015.
  34. W. Roy Knowles. Hair loss prevention. USP2002076420352.
  35. Breitenbach, Armin; Wolff, Hans-Michael. Hot melt TTS for administering rotigotine. USP2015119186335.
  36. Breitenbach, Armin; Wolff, Hans-Michael. Hot-melt TTS for administering rotigotine. USP2012078211462.
  37. Charles, Matthew; Kolodka, Tadeusz; Williams, Mark. Human tissue kallikrein 1 glycosylation isoforms. USP2017129839678.
  38. Charles, Matthew; Kolodka, Tadeusz; Williams, Mark. Human tissue kallikrein 1 glycosylation isoforms. USP2016069364521.
  39. Cleary, Gary W.; Parandoosh, Shoreh; Feldstein, Mikhail M.; Chalykh, Anatoly E.; Platé, Nicolai A.; Kulichikhin, Valery G.. Hydrogel Compositions. USP2014058728445.
  40. Cleary, Gary W.; Parandoosh, Shoreh; Feldstein, Mikhail M.; Chalykh, Anatoly E.; Platé, Nicolai A.; Kulichikhin, Valery G.. Hydrogel compositions. USP2013078481059.
  41. Singh, Parminder; Cleary, Gary W.; Mudumba, Sri; Feldstein, Mikhail M.; Bairamov, Danir R.. Hydrogel compositions demonstrating phase separation on contact with aqueous media. USP2015079089481.
  42. Singh, Parminder; Cleary, Gary W.; Mudumba, Sri; Feldstein, Mikhail M.; Bairamov, Danir R.. Hydrogel compositions demonstrating phase separation on contact with aqueous media. USP2013098541021.
  43. Singh, Parminder; Cleary, Gary W.; Mudumba, Sri; Feldstein, Mikhail M.; Bairamov, Danir R.. Hydrogel compositions for tooth whitening. USP2014098840918.
  44. Singh, Parminder; Cleary, Gary W.; Mudumba, Sri; Feldstein, Mikhail M.; Bayramov, Danir F.. Hydrogel compositions for tooth whitening. USP2017069687428.
  45. Singh, Parminder; Cleary, Gary W.; Mudumba, Sri; Feldstein, Mikhail M.; Bayramov, Danir F.. Hydrogel compositions for tooth whitening. USP2017019532935.
  46. Singh, Parminder; Cleary, Gary W.; Mudumba, Sri; Feldstein, Mikhail M.; Bayramov, Danir F.. Hydrogel compositions for tooth whitening. USP20190110179096.
  47. Singh, Parminder; Faasse, Adrian; Cleary, Gary W.; Mudumba, Sri; Feldstein, Mikhail M.; Bairamov, Danir F.. Hydrogel compositions with an erodible backing member. USP2014068741331.
  48. Singh, Parminder; Faasse, Adrian; Cleary, Gary W.; Mudumba, Sri; Feldstein, Mikhail M.; Bairamov, Danir F.. Hydrogel compositions with an erodible backing member. USP2013078481071.
  49. Singh, Parminder; Faasse, Adrian; Cleary, Gary W.; Mudumba, Sri; Feldstein, Mikhail M.; Bairamov, Danir R.. Hydrogel compositions with an erodible backing member. USP2012068206738.
  50. Singh, Parminder; Faasse, Adrian; Cleary, Gary W.; Mudumba, Sri; Feldstein, Mikhail M.; Bayramov, Danir F.. Hydrogel compositions with an erodible backing member. USP2015079084723.
  51. Stoesz, James D.; Statham, Alexis S.; Truong, Myhanh T.. Immune response modifier compositions and methods. USP2012028124096.
  52. Statham, Alexis S.; Nelson, Robert J.. Immune response modifier formulations containing oleic acid and methods. USP2010027655672.
  53. Statham, Alexis S.; Nelson, Robert J.. Immune response modifier formulations containing oleic acid and methods. USP2013108557838.
  54. Landrau Felix A. ; Nedberge Diane E. ; Hearney Linda M.. Incorporating poly-N-vinly amide in a transdermal system. USP2001066248348.
  55. Landrau Felix A. ; Nedberge Diane E. ; Hearney Linda Mary. Incorporating poly-N-vinyl amide in a transdermal system. USP1999075919478.
  56. Rimpler,Stephan; Grapatin,Sabine; Krein,Cliff; Thelen,Markus. Injectable pharmaceutical composition for systematic administration of pharmacologically active ingredients. USP2007127309497.
  57. Seigfried, Bernd G.. Liquid compositions capable of foaming and including active agents, and methods for making or developing same. USP2017079693956.
  58. Schott, Kevin. Low-pressure packaging for fluid devices. USP2013108561795.
  59. Chang, Yunik; Lathrop, Robert; Böhm, Erwin; Gander-Meisterernst, Irene; Greger, Regina; Holldack, Johanna; Moebius, Ulrich. Medicament for the treatment of viral skin and tumour diseases. USP2010127858662.
  60. Chang, Yunik; Lathrop, Robert; Böhm, Erwin; Gander-Meisterernst, Irene; Greger, Regina; Holldack, Johanna; Moebius, Ulrich. Medicament for the treatment of viral skin and tumour diseases. USP2017099770406.
  61. Mitragotri, Samir S.; Kost, Joseph; Kellogg, Scott C.; Warner, Nicholas F.; Elstrom, Tuan A.. Method and apparatus for enhancement of transdermal transport. USP2012108287483.
  62. Mitragotri, Samir S.; Kost, Joseph; Kellogg, Scott C.; Warner, Nicholas F; Elstrom, Tuan A. Method and apparatus for enhancement of transdermal transport. USP2014108870810.
  63. Lehman, Leah M.; Simes, Stephen M.. Method and apparatus for transdermal or transmucosal application of testosterone. USP2011118067399.
  64. Smith, Alan; Eppstein, Jonathan A.; Messier, Bernadette; Novakovic, Zoran; McRae, Stuart. Method for transdermal delivery of permeant substances. USP2011098016811.
  65. Smith, Alan; Eppstein, Jonathan A.; Messier, Bernadette; Novakovic, Zoran; McRae, Stuart. Method for transdermal delivery of permeant substances. USP2015059033950.
  66. Skover, Gregory. Method of distributing skin care products. USP2005016840910.
  67. Skover, Gregory. Method of examining and diagnosing skin health. USP2004096790179.
  68. Feldstein, Mikhail M.; Bairamov, Danir F.; Platé, Nicolai A.; Kulichikhin, Valery G.; Chalykh, Anatoly E.; Cleary, Gary W.; Singh, Parminder. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components. USP2014098821901.
  69. Skover, Gregory. Method of treating the skin of a subject. USP2005026855117.
  70. Lehman, Leah M.; Simes, Stephen M.. Methods and apparatus for transdermal or transmucosal application of testosterone. USP2012128338400.
  71. Muhammad, Naweed; Jamieson, Gene Curtis; Bley, Keith R.; Chanda, Sanjay. Methods and compositions for administration of TRPV1 agonists. USP2017099750707.
  72. Muhammad, Naweed; Jamieson, Gene Curtis; Bley, Keith R.; Chanda, Sanjay. Methods and compositions for administration of TRPV1 agonists. USP2014058734770.
  73. Muhammad, Naweed; Jamieson, Gene Curtis; Bley, Keith R.; Chanda, Sanjay. Methods and compositions for administration of TRPV1 agonists. USP2012098273390.
  74. Muhammad, Naweed; Jamieson, Gene Curtis; Bley, Keith R.; Chanda, Sanjay. Methods and compositions for administration of TRPV1 agonists. USP2012098263093.
  75. Lagos González, Marcelo Santiago. Methods for producing phycotoxins. USP2015028957207.
  76. Lagos Gonzalez, Marcelo Santiago. Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof. USP2016029249150.
  77. Lagos González, Marcelo Santiago. Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof. USP2015028952152.
  78. Simes, Stephen M.; Lehman, Leah M.. Methods of treating hot flashes with formulations for transdermal or transmucosal application. USP2014028647665.
  79. Simes, Stephen M.; Lehman, Leah M.. Methods of treating hot flashes with formulations for transdermal or transmucosal application. USP2012098268346.
  80. Eppstein, Jonathan A.. Microporation of tissue for delivery of bioactive agents. USP2010077758561.
  81. Eppstein, Jonathan A.. Microporation of tissue for delivery of bioactive agents. USP2017029579380.
  82. Wantier Henri (Dour BEX) Mathieu Fabienne (Nivelles BEX) Baudrihaye Marc (Waterloo BEX) Delacroix Dominique (Kraainem BEX). Microspheres for the controlled release of water-soluble substances and process for preparing them. USP1997035609886.
  83. Levinson, Douglas A.; Bernstein, Howard; Chickering, III, Donald E.. Monitoring or feedback systems and methods. USP2015059041541.
  84. Lee Eun Soo ; Watanabe Tyler ; Gale Robert M. ; Burkoth Terry L.. Monoglyceride/lactate ester permeation enhancer for oxybutnin. USP1999055900250.
  85. Lee Eun Soo ; Watanabe Tyler ; Gale Robert M. ; Burkoth Terry L.. Monoglyceride/lactate ester permeation enhancer for oxybutynin. USP1998055747065.
  86. Berde, Charles; Kohane, Daniel S.. Neosaxitoxin combination formulations for prolonged local anesthesia. USP2015038975268.
  87. Berde, Charles; Kohane, Daniel S.. Neosaxitoxin combination formulations for prolonged local anesthesia. USP2015038975281.
  88. Cleary, Gary W.; Parandoosh, Shoreh; Feldstein, Mikhail M.; Chalykh, Anatoly E.; Platè, Nicolai A.; Kulichikhin, Valery G.. Non-electrically conductive hydrogel composition. USP2016029259504.
  89. De-chu C. Tang ; Donald H. Marks ; David T. Curiel ; Zhongkai Shi ; Kent Rigby van Kampen. Noninvasive genetic immunization, expression products therefrom and uses thereof. USP2002026348450.
  90. Tang, De-chu C.; Marks, Donald H.; Curiel, David T.; Shi, Zhongkai. Noninvasive genetic immunization, expression products therefrom, and uses thereof. USP2004046716823.
  91. Statham, Alexis S.; Henderson, Julie M.; Lundquist, Kevin G.. Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation. USP2014118889154.
  92. Sharma, Sanjay; Warner, Kevin S.; Zhang, Jie; Yan, Guang. Patches, formulations, and associated methods for transdermal delivery of alprazolam and other drugs. USP2015018927537.
  93. Mak Vivien H. W. ; Grayson Stephen. Penetration enhancing and irritation reducing systems. USP2001116319913.
  94. Mak, Vivien H. W.; Grayson, Stephen. Penetration enhancing and irritation reducing systems. USP2003066579865.
  95. Mak,Vivien H. W.; Grayson,Stephen. Penetration enhancing and irritation reducing systems. USP2007017157097.
  96. Lee Eun Soo ; Yum Su II. Permeation enhances for transdermal drug delivery compositions, devices and methods. USP1999126004578.
  97. Grenier,Arnaud; Carrara,Dario Norberto R.; Besse,Celine. Permeation enhancing compositions for anticholinergic agents. USP2008097425340.
  98. Hiromoto, Bryan. Pesticide microemulsions and dispersant/penetrant formulations. USP2004046720170.
  99. Hiromoto,Bryan. Pesticide microemulsions and dispersant/penetrant formulations. USP2007117297351.
  100. Dudley, Robert E.; Drouin, Dominique. Pharmaceutical composition and method for treating hypogonadism. USP2015099132089.
  101. Dudley, Robert E.; Drouin, Dominique. Pharmaceutical composition and method for treating hypogonadism. USP2015099125816.
  102. Dudley, Robert E.; Kottayil, S. George; Palatchi, Olivier. Pharmaceutical composition and method for treating hypogonadism. USP2003016503894.
  103. Haghgooie, Ramin; Chickering, III, Donald E.; Davis, Shawn; Michelman, Mark; Bernstein, Howard; Horton, Kristin. Plasma or serum production and removal of fluids under reduced pressure. USP2015099119578.
  104. Haghgooie, Ramin; Chickering, III, Donald E.; Davis, Shawn; Michelman, Mark; Bernstein, Howard; Horton, Kristin. Plasma or serum production and removal of fluids under reduced pressure. USP20190110188335.
  105. Kurt Leander CH; Jan Gunzinger CH; Borje Rosen SE. Podophyllotoxin preparation containing triglycerides. USP2002086440428.
  106. Feldstein, Mikhail M.; Platè, Nicolai A.; Chalykh, Anatoly E.; Cleary, Gary W.. Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties. USP201304RE44145.
  107. Feldstein, Mikhail M.; Platè, Nicolai A.; Chalykh, Anatoly E.; Cleary, Gary W.. Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties. USP201509RE45666.
  108. Venkateshwaran Srinivasan ; Fikstad David ; Ebert Charles D.. Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents. USP1999115985317.
  109. Singh, Parminder; Mudumba, Sri; Bairamov, Danir R.; Kulichikhin, Valery G.; Feldstein, Mikhail M.; Cleary, Gary W.. Rapidly dissolving film for delivery of an active agent. USP2014028658201.
  110. Singh, Parminder; Mudumba, Sri; Bayramov, Danir F.; Kulichikhin, Valery G.; Feldstein, Mikhail M.; Cleary, Gary W.. Rapidly dissolving film for delivery of an active agent. USP2015099144552.
  111. Chickering, III, Donald E.; Bernstein, Howard; Davis, Shawn; Haghgooie, Ramin; Levinson, Douglas A.; Michelman, Mark; Gong, Ping. Sampling devices and methods involving relatively little pain. USP2015059033898.
  112. Kohane, Daniel S.; Sagie, Itay. Sensory-specific local anesthesia and prolonged duration local anesthesia. USP2013128609733.
  113. Chuang, Han; Eslava, Juan P.; Hurley, James P.; Ghosh, Debashis; Krystyniak, Keith; Kellogg, Scott C.. Skin permeation device for analyte sensing or transdermal drug delivery. USP2013028386027.
  114. Chuang, Han; Eslava, Juan P.; Hurley, James P.; Ghosh, Debashis; Krystyniak, Keith; Kellogg, Scott C.. Skin permeation device for analyte sensing or transdermal drug delivery. USP2017029572527.
  115. Beste Russell D. ; Hamlin Richard D.. Skin permeation enhancer compositions comprising a monoglyceride and ethyl palmitate. USP2001076267984.
  116. Lee Eun Soo ; Yum Su Il. Skin permeation enhancer compositions using acyl lactylates. USP1999035882676.
  117. Kellogg, Scott C.; Chuang, Han. System and method for analyte sampling and analysis with hydrogel. USP2012078224414.
  118. Custer,Linda; Elstrom,Tuan A.; Kellogg,Scott C.; Kost,Joseph; Warner,Nicholas F.. System, method, and device for non-invasive body fluid sampling and analysis. USP2006067066884.
  119. Brancazio, David. Systems and interfaces for blood sampling. USP2014088808202.
  120. Haghgooie, Ramin; Chickering, III, Donald E.; Davis, Shawn; Michelman, Mark; Chu, Li Yang. Systems and methods for collecting fluid from a subject. USP2016039295417.
  121. Malladi, Ramana; Miller, Jodi. Testosterone gel and method of use. USP2013068466138.
  122. Malladi, Ramana; Miller, Jodi. Testosterone gel and method of use. USP2013078486925.
  123. Malladi, Ramana; Stahlman, Jodi. Testosterone gel and method of use. USP2013068466136.
  124. Malladi, Ramana; Stahlman, Jodi. Testosterone gel and method of use. USP2013068466137.
  125. Malladi, Ramana; Stahlman, Jodi. Testosterone gel and method of use. USP2014068759329.
  126. Malladi, Ramana; Stahlman, Jodi. Testosterone gel and method of use. USP2014068754070.
  127. Malladi, Ramana; Stahlman, Jodi. Testosterone gel and method of use. USP2014068741881.
  128. Malladi, Ramana; Stahlman, Jodi. Testosterone gel and method of use. USP2014058729057.
  129. Pimplaskar, Harish K.. Testosterone gel compositions and related methods. USP2017059662340.
  130. Pimplaskar, Harish K.. Testosterone gel compositions and related methods. USP2014078785426.
  131. Pimplaskar, Harish K.. Testosterone gel compositions and related methods. USP2016039295675.
  132. Knowles W. Roy. Topical composition for fungal treatment. USP1999035889039.
  133. Knowles W. Roy (10919 Kemwood Dr. Houston TX 77024). Topical composition for fungal treatment. USP1997075652256.
  134. Wick Steven M. ; Schultz Helen Jensen ; Nelson Gregory R. ; Mitra Amit K. ; Berge Stephen M.. Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-C]quinolin-4-amine. USP1998045736553.
  135. Vaidyanathan Rajaram ; Vo Phuong M. ; Manning George N. ; Gerhart Donald J. ; Helmy Atef A. ; Allan Geoffrey. Topical formulations comprising skin penetration agents and the use thereof. USP2001086271219.
  136. Singh, Parminder; Lee, Eun Soo; Jain, Amit K.. Transdermal administration of tamsulosin. USP2017049610253.
  137. Singh, Parminder; Lee, Eun Soo; Jain, Amit K.. Transdermal administration of tamsulosin. USP20190310238612.
  138. Singh, Parminder; Lee, Eun Soo; Jain, Amit K.. Transdermal administration of tamsulosin. USP2014078784879.
  139. Chuang, Han; Hurley, James P.; Kost, Joseph. Transdermal analyte monitoring systems and methods for analyte detection. USP2014088812071.
  140. Carrara, Dario Norberto R.; Grenier, Arnaud. Transdermal compositions for anticholinergic agents. USP2014028652491.
  141. Carrara, Dario Norberto R.; Grenier, Arnaud. Transdermal compositions for anticholinergic agents. USP2015038980290.
  142. Santus Giancarlo (Milan ITX) Kim Aeri (Taejon KRX) Francoeur Michael L. (Los Altos CA) Bremer Ulrike (Menlo Park CA). Transdermal delivery of alpha adrenoceptor blocking agents. USP1997085658587.
  143. Ebert Charles D. (Salt Lake City UT) Heiber Werner (Salt Lake City UT) Good William R. (Salt Lake City UT) Venkateshwaran Srinivasan (Salt Lake City UT). Transdermal delivery system with adhesive overlay and peel seal disc. USP1997095662925.
  144. Eppstein, Jonathan; McRae, Stuart. Transdermal integrated actuator device, methods of making and using same. USP2016119486616.
  145. Eppstein, Jonathan; McRae, Stuart. Transdermal integrated actuator device, methods of making and using same. USP2014048706210.
  146. Eppstein, Jonathan; McRae, Stuart. Transdermal integrated actuator device, methods of making and using same. USP2013088517958.
  147. McRae, Stuart; Bowerman, Wendy E.; Braun, Stephen Wilson; Spiehl, Regina; Messier, Bernadette; Farquhar, David; Henkel, Erin Koch; O'Leary, Jeremiah Peter; Fisher, Mark James; Kascak, Uros; Lantz, Loren J.; Novakovic, Zoran; Eppstein, Jonathan. Transdermal porator and patch system and method for using same. USP2018039918665.
  148. Messier, Bernadette; Novakovic, Zoran; O'Leary, Jeremiah Peter; Spiehl, Regina; Bowerman, Wendy E.; Braun, Stephen Wilson; Eppstein, Jonathan; Farquhar, David; Fisher, Mark James; Kascak, Uros; Henkel, Erin Koch; Lantz, Loren J.; McRae, Stuart. Transdermal porator and patch system and method for using same. USP2012028116860.
  149. Messier, Bernadette; Novakovic, Zoran; O'Leary, Jeremiah Peter; Spiehl, Regina; Bowerman, Wendy E.; Braun, Stephen Wilson; Eppstein, Jonathan; Farquhar, David; Fisher, Mark James; Kascak, Uros; Henkel, Erin Koch; Lantz, Loren J.; McRae, Stuart. Transdermal porator and patch system and method for using same. USP2014028641689.
  150. Mitragotri Samir S. ; Blankschtein Daniel ; Langer Robert S.. Transdermal protein delivery or measurement using low-frequency sonophoresis. USP2000016018678.
  151. Mitragotri Samir S. ; Blankschtein Daniel ; Langer Robert S.. Transdermal protein delivery using low-frequency sonophoresis. USP1999126002961.
  152. Carrara, Dario Norberto R.; Grenier, Arnaud. Transdermal testosterone formulation for minimizing skin residues. USP2015038980309.
  153. Müller, Walter; Peck, James V.. Transdermal therapeutic system and method of use thereof for treating parkinsonism. USP20190410251844.
  154. Place Virgil A.. Transurethral administration of androgenic agents for the treatment of erectile dysfunction. USP1999075925629.
  155. Cleary, Gary W.; Feldstein, Mikhail M.; Kulichikhin, Valery G.; Bairamov, Danir F.. Two-phase, water-absorbent bioadhesive composition. USP2014068753669.
  156. Rowe Stephen ; Kost Joseph,ILX ; Mitragotri Samir S. ; Pishko Michael ; Davis Matthew. Ultrasound enhancement of transdermal transport. USP2001056234990.
  157. Stephen Rowe ; Joseph Kost IS; Samir S. Mitragotri ; Michael Pishko ; Matthew Davis. Ultrasound enhancement of transdermal transport. USP2002126491657.
  158. Stockfleth, Eggert. Use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin. USP2015069060998.
  159. Stockfleth, Eggert. Use of a polyphenol for the treatment of a cancerous or precancerous lesion of the skin. USP2013068455022.
  160. Scheller, Dieter; Breidenbach, Alexander; Selve, Norma. Use of rotigotine for the treatment of depression. USP2014068754119.
  161. Tang, De-chu; Marks, Donald H.; Curiel, David T.; Shi, Zhongkai. Vaccination by topical application of genetic vectors. USP2004036706693.
  162. Feldstein, Mikhail M.; Bairamov, Danir F.; Novikov, Mikhail Borisovich; Kulichikhin, Valery G.; Platé, Nicolai A.; Cleary, Gary W.; Singh, Parminder. Water-absorbent adhesive compositions and associated methods of manufacture and use. USP2012098273405.
  163. Feldstein, Mikhail M.; Bairamov, Danir F.; Novikov, Mikhail Borisovich; Kulichikhin, Valery G.; Platé, Nicolai A.; Cleary, Gary W.; Singh, Parminder. Water-absorbent adhesive compositions and associated methods of manufacture and use. USP2013128617647.
  164. Feldstein, Mikhail M.; Bayramov, Danir F.; Novikov, Mikhail Borisovich; Kulichikhin, Valery G.; Platè, Nicolai A.; Cleary, Gary W.; Singh, Parminder. Water-absorbent adhesive compositions and associated methods of manufacture and use. USP2015099127140.
  165. Marcoux, Michael G.; Johnson, David R.; Klemm, Steven R.. Wound dressing, ingredient delivery device and IV hold-down, and method relating to same. USP2017129839560.

IPC 상위 출원인